相关实验视频
Updated: Jun 24, 2025

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
6.6K
在肥胖中降低心脏代谢风险的GLP-1 RA - 我们如何最好地描述好处和价值?
1MedStar Georgetown University Hospital, Washington, D.C. 20007, United States.
American journal of preventive cardiology
|June 6, 2024
概括
评估类似葡萄糖类-1受体激动剂 (GLP1-RAs) 需要超越单个心血管事件. 一个新的框架扩大了结果分析,以捕捉跨心脏-脏-代谢疾病的更广泛的益处.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
背景情况:
- 目前GLP1-RAs的临床试验往往仅集中在动脉样硬化心血管疾病 (ASCVD) 终点上,如主要心血管不良事件 (MACE).
- 这种有限的范围可能会忽视GLP1-RAs在各种并发症中的多方面的好处.
- 需要进行全面的评估,才能充分了解这些药物的价值.
研究的目的:
- 为扩大GLP1-RAs的大型临床试验的结果分析提出框架.
- 促进对整个心脏-脏-代谢 (CKM) 谱的GLP1-RA益处的更全面的理解.
- 为患者护理,临床指南和保险覆盖决定提供信息.
主要方法:
- 该研究概述了临床试验结果评估的概念框架.
- 它主张包括传统MACE之外的更广泛的终点范围.
- 该框架强调在CKM频谱内的多重共发病性评估.
主要成果:
- 拟议的框架允许对GLP1-RA疗效进行更全面的评估.
- 它超越了单一的终点评估,转向了多系统的视角.
- 这种方法预计将揭示GLP1-RAs的更广泛的好处.
结论:
- 更广泛的结果评估框架对于理解GLP1-RAs的全部价值至关重要.
- 这种跨CKM范围的整体方法将增强临床决策.
- 该框架支持基于证据的指导方针和GLP1-RAs的保险覆盖.
相关概念视频
Glucagon-like Receptor Agonists
316
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
316
Dipeptidyl Peptidase 4 Inhibitors
181
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
181
Oral Hypoglycemic Agents: Biguanides and Glitazones
189
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
189
Oral Hypoglycemic Agents: Glinides
152
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
152
G Protein-coupled Receptors
11.8K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.8K
Regulation of Food Intake
220
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
220

